Complications relating to intravenous buprenorphine abuse: A single institution case series

Annals of the Academy of Medicine Singapore

Volumn 35, Issue 7, 2006, Pages 487-491

  Yeo, Andy K S ^a   Chan, Chung Yip ^b   Chia, Kok Hoong ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Femoral vein; Heroin; Pseudoaneurysm; Thrombus

Indexed keywords

ANALGESIC AGENT; BUPRENORPHINE;

ADULT; ANEURYSM; ARTERY SPASM; ARTICLE; BYPASS SURGERY; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG ABUSE; EMBOLECTOMY; FEMALE; FOLLOW UP; HUMAN; LIMB AMPUTATION; MALE; NEUROPATHY; SYMPATHETIC DYSTROPHY; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 33749038366     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Warner RM, Srinivasan JR. Protean manifestations of intravenous drug abuse. Surgeon 2004;2:137-40.
2. Del Giudice P. Cutaneous complications of intravenous drug abuse. Br J Dermatol 2004;150:1-10.
3. Cazorla C, Grenier de Cardenal D, Schuhmacher H, Thomas L, Wack A, May T, et al. Infectious complications and misuse of high-dose buprenorphine. Presse Med 2005;34:719-24.
4. Elkader A, Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet 2005;44:661-80.
5. Wang YQ, Wang Y, Cai BN, Liu WH, Chen SL, Dong JZ, et al. Clinical analysis of 1,400 cases of coronary artery angiography without heparin. [Chinese] Di Yi Jun Yi Da Xue Xue Bao 2005;25:1429-31.
6. Demirbas O, Batyraliev T, Eksi Z, Pershukov I. Femoral pseudoaneurysm due to diagnostic or interventional angiographic procedures. Angiology 2005;56:553-6.
7. Fontaa V, Bronner C. Persistent injecting practices in subjects on methadone or buprenorphine maintenance therapy. A study of 600 cases [French]. Ann Med Interne (Paris) 2001;152 Suppl 7:59-69.
8. Guichard A, Lert F, Calderon C, Gaigi H, Maguet O, Soletti J, et al. Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction 2003;98:1585-97.
9. Jenkinson RA, Clark NC, Fry CL, Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction 2005;100:197-205.
10. Cowling L, Ali R, White J. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev 2006;19:CD002025.
11. Bell J, Byron G, Gibson A, Morris A. A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence. Drug Alcohol Rev 2004;23:311-7.